Home1PG • FRA
add
Aker Biomarine ASA
Previous close
€5.56
Day range
€5.63 - €5.63
Year range
€3.80 - €8.91
Avg Volume
39.00
P/E ratio
-
Dividend yield
-
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 50.80M | 4.74% |
Operating expense | 20.20M | -11.79% |
Net income | -3.10M | 73.95% |
Net profit margin | -6.10 | 75.14% |
Earnings per share | — | — |
EBITDA | 4.10M | -57.73% |
Effective tax rate | -42.86% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 16.00M | -50.00% |
Total assets | 389.60M | -52.11% |
Total liabilities | 219.00M | -52.27% |
Total equity | 170.60M | — |
Shares outstanding | 87.69M | — |
Price to book | 2.85 | — |
Return on assets | -0.13% | — |
Return on capital | -0.15% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -3.10M | 73.95% |
Cash from operations | -10.90M | -626.67% |
Cash from investing | -2.60M | 43.48% |
Cash from financing | 14.50M | 38.10% |
Net change in cash | 1.00M | -77.27% |
Free cash flow | -11.14M | -474.37% |
About
Aker BioMarine is a leading human health and nutrition innovator that develops krill-derived products for consumer health and nutrition. Krill is a natural, powerful, and health-promoting source of nutrients from the pristine waters of Antarctica, and Aker BioMarine has a unique position in its industry. The ingredient portfolio consists of Superba Krill Oil, Lysoveta, FloraMarine, and PL+, as well as the consumer brand, Kori Krill. The innovative approach also extends into the spin-offs AION and Understory. Aker BioMarine is listed on the Oslo Stock Exchange. Wikipedia
Founded
2006
Website
Employees
249
